Hansoh Pharmaceutical Group Company Limited (03692) said "fosaprepitant dimeglumine for injection" (product name "Tanneng") developed by its subsidiary Jiangsu Hansoh Pharmaceutical Group Co., Ltd. has been granted drug registration approval by the National Medical Products Administration of the People's Republic of China and obtained approval for marketing.
Tanneng is used for the prevention of acute and delayed nausea and vomiting caused by chemotherapy.
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情